
What smart money is saying about PDEX
2 funds in our archive have pitched PDEX — most recently Long Cast Advisers Small- & Micro-Cap Concentrated Strategy in June 2026.
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Get an email when a fund writes about it
Fund coverage · 2 theses
- Long Cast Advisers Small- & Micro-Cap Concentrated StrategyJune 2026
PDEX could benefit from Zimmer’s mBos robot commercialization, with potential for a major operating cash flow transformation and much higher corporate value.
Read the full thesis - Long Cast AdvisersMarch 2026
PDEX is a critical contracted supplier with near-term earnings support and long-term upside tied to Monogram’s commercialization and valuation rights.
Read the full thesis
Read every full thesis on PDEX
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→